Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LimmaTech Chlamydia vaccine
- Development stage
- Preclinical
- Lead developer
- LimmaTech Biologics
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
01
Overview
LimmaTech Chlamydia vaccine is a preclinical-stage multivalent vaccine candidate being developed by LimmaTech Biologics for the prevention of Chlamydia infections. The vaccine is produced using a proprietary E. coli-based expression platform that enables the creation of complex vaccines combining both carbohydrate and protein antigens in a single, scalable production step. This platform technology is designed to be self-adjuvanting, aiming to elicit a robust immune response against Chlamydia trachomatis. The program targets a high unmet medical need in the field of sexually transmitted infections and antimicrobial resistance, where no approved vaccines currently exist.
- Other names
- LimmaTech Chlamydia vaccine candidate
02
Targets
Chlamydia trachomatis
Beyond the preview
Go deeper on LimmaTech Chlamydia vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LimmaTech Chlamydia vaccine.